The order of administration of trastuzumab to SN-38 infl uences SN-38's cytotoxicity in gastric cancer cell lines with or without HER2 expression

被引：0
|
作者：
Yamade, M. [1 ]
Sugimoto, M. [1 ]
Nishino, M. [1 ]
Uotani, T. [1 ]
Sahara, S. [1 ]
Furuta, T. [2 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [1] The Order of Addition of Trastuzumab and Topoisomerase-1 Inhibitor (SN-38) Influences SN-38's Cytotoxic Effects on Gastric Cancer Cell Lines Positive or Negative for HER2 Expression
    Yamade, Mihoko
    Uotani, Takahiro
    Nishino, Masafumi
    Kodaira, Chise
    Sugimoto, Mitsushige
    Ikuma, Mutsuhiro
    Furuta, Takahisa
    GASTROENTEROLOGY, 2011, 140 (05) : S821 - S821
  • [2] Effect of Trastuzumab on Phosphorylated Histone H2AX Induced by Topoisomerase-1 Inhibitor (SN-38) in Gastric Cancer Cell Lines With or Without HER2 Expression
    Yamade, Mihoko
    Furuta, Takahisa
    Sugimoto, Mitsushige
    Kodaira, Chise
    Nishino, Masafumi
    Uotani, Takahiro
    Ikuma, Mutsuhiro
    GASTROENTEROLOGY, 2010, 138 (05) : S730 - S730
  • [3] Gene Expression Profile of Colon Cancer Cell Lines Treated with SN-38
    Wallin, A.
    Francis, P.
    Nilbert, M.
    Svanvik, J.
    Sun, X. -F.
    CHEMOTHERAPY, 2010, 56 (01) : 17 - 25
  • [4] Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitro
    Tanaka, R
    Ariyama, H
    Qin, BL
    Shibata, Y
    Takii, Y
    Kusaba, H
    Baba, E
    Mitsugi, K
    Harada, M
    Nakano, S
    ONCOLOGY REPORTS, 2005, 14 (03) : 683 - 688
  • [5] Determinants of CPT-11 and SN-38 cytotoxicity in colon carcinoma cell lines.
    Quinney, SK
    Murry, DJ
    Sanghani, SP
    Boston, WF
    PHARMACOTHERAPY, 2003, 23 (03): : 407 - 407
  • [6] Anticancer effect of SN-38 on colon cancer cell lines with different metastatic potential
    Wallin, Asa
    Svanvik, Joar
    Holmlund, Birgitta
    Ferreud, Lillianne
    Sun, Xiao-Feng
    ONCOLOGY REPORTS, 2008, 19 (06) : 1493 - 1498
  • [7] Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines
    Haatisha Jandu
    Kristina Aluzaite
    Louise Fogh
    Sebastian Wingaard Thrane
    Julie B. Noer
    Joanna Proszek
    Khoa Nguyen Do
    Stine Ninel Hansen
    Britt Damsgaard
    Signe Lykke Nielsen
    Magnus Stougaard
    Birgitta R. Knudsen
    José Moreira
    Petra Hamerlik
    Madhavsai Gajjar
    Marcel Smid
    John Martens
    John Foekens
    Yves Pommier
    Nils Brünner
    Anne-Sofie Schrohl
    Jan Stenvang
    BMC Cancer, 16
  • [8] Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines
    Jandu, Haatisha
    Aluzaite, Kristina
    Fogh, Louise
    Thrane, Sebastian Wingaard
    Noer, Julie B.
    Proszek, Joanna
    Khoa Nguyen Do
    Hansen, Stine Ninel
    Damsgaard, Britt
    Nielsen, Signe Lykke
    Stougaard, Magnus
    Knudsen, Birgitta R.
    Moreira, Jose
    Hamerlik, Petra
    Gajjar, Madhavsai
    Smid, Marcel
    Martens, John
    Foekens, John
    Pommier, Yves
    Brunner, Nils
    Schrohl, Anne-Sofie
    Stenvang, Jan
    BMC CANCER, 2016, 16
  • [9] In vitro cytotoxicity of chemoradiation with SN-38 in human colorectal cancer cells.
    Balcer-Kubiczek, E
    Wood, A
    Kennedy, AS
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3807S - 3807S
  • [10] Targeting efficacy and anticancer activity of polymeric nanoparticles of SN-38 on colon cancer cell lines
    Prasad, Shilpi
    Dangi, J. S.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 9 (01)
12345